Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

2.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

121
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
121
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

558
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
558
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

429
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
429
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

123
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
123
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

79
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
79

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut Microbiota Composition and Plasma Metabolomic Profile Are Associated with Amyloid Pathology and Cognitive Performance in Patients with Mild Cognitive Impairment.

Nutrients·2026
Same author

Impact of social determinants of health on cardiovascular health.

Current opinion in cardiology·2026
Same author

Incidence of major adverse cardiovascular events decreases with greater adherence to both Mediterranean and low-fat dietary patterns in secondary prevention patients: a randomized controlled trial.

European journal of internal medicine·2026
Same author

Telomere length is associated with arterial damage in the CORDIOPREV study.

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis·2025
Same author

Sex-differences in endotoxemia and trimethylamine N-oxide according to the diet and type 2 diabetes status in coronary heart disease patients: from the CORDIOPREV study.

Frontiers in cardiovascular medicine·2025
Same author

Health inequity in metabolic disorders and lifestyle behaviors in under-resourced adolescents: a cross-sectional study from E-DUCASS Program.

American journal of preventive cardiology·2025

Related Experiment Video

Updated: Oct 30, 2025

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
07:35

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess

Published on: June 1, 2022

2.4K

Coenzyme Q10 and Cardiovascular Diseases.

Francisco M Gutierrez-Mariscal1,2, Silvia de la Cruz-Ares1,2, Jose D Torres-Peña1,2

  • 1Lipids and Atherosclerosis Unit, Unidad de Gestión Clínica de Medicina Interna, Maimonides Institute for Biomedical Research in Córdoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, 14004 Córdoba, Spain.

Antioxidants (Basel, Switzerland)
|July 2, 2021
PubMed
Summary

Coenzyme Q10 (CoQ10) supplementation may help reduce cardiovascular disease risk factors and complications. This review explores CoQ10

Keywords:
cardiovascular diseasescoenzyme Q10ubiquinolubiquinone

More Related Videos

Inner Mitochondrial Membrane Sensitivity to Na+ Reveals Partially Segmented Functional CoQ Pools
05:27

Inner Mitochondrial Membrane Sensitivity to Na+ Reveals Partially Segmented Functional CoQ Pools

Published on: July 20, 2022

2.1K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.8K

Related Experiment Videos

Last Updated: Oct 30, 2025

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
07:35

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess

Published on: June 1, 2022

2.4K
Inner Mitochondrial Membrane Sensitivity to Na+ Reveals Partially Segmented Functional CoQ Pools
05:27

Inner Mitochondrial Membrane Sensitivity to Na+ Reveals Partially Segmented Functional CoQ Pools

Published on: July 20, 2022

2.1K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.8K

Area of Science:

  • Biochemistry and Molecular Biology
  • Cardiology
  • Nutritional Science

Background:

  • Coenzyme Q10 (CoQ10) is vital for cellular energy production and acts as an antioxidant.
  • CoQ10 deficiency is linked to chronic and age-related diseases, including cardiovascular diseases (CVDs).
  • Statin use for lowering lipids reduces CoQ10 bioavailability due to shared biosynthesis pathways.

Purpose of the Study:

  • To review recent advances in CoQ10 supplementation for cardiovascular health.
  • To examine the clinical implications of CoQ10 supplementation in reducing cardiovascular risk factors.
  • To assess CoQ10's therapeutic potential in managing CVD complications.

Main Methods:

  • Literature review of clinical trials on CoQ10 supplementation in CVD.
  • Analysis of studies investigating CoQ10's impact on lipid profiles, blood pressure, and endothelial function.
  • Evaluation of CoQ10's role in mitigating CVD clinical outcomes.

Main Results:

  • CoQ10 supplementation has been studied for its potential to ameliorate CoQ10 deficiencies in CVD patients.
  • Clinical trials have explored CoQ10's effects on cardiovascular risk factors like lipid levels and blood pressure.
  • Evidence suggests CoQ10 may play a role in reducing CVD complications.

Conclusions:

  • CoQ10 supplementation shows promise in addressing CoQ10 bioavailability issues in CVD.
  • Further research supports CoQ10's role in managing cardiovascular risk factors and complications.
  • CoQ10 supplementation is a potential therapeutic strategy for improving cardiovascular health.